+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 5 Actively Recruiting clinical trials

P

Actively Recruiting

Researchers are investigating the effects of an experimental drug called BNT323 also known as DB-1303 compared with standard chemotherapy in women with recurrent endometrial cancer that expresses the HER2 protein. This Phase III study includes two groups based on HER2 levels one group with lower HER2 expression 1 or 2 who have previously received immune checkpoint inhibitors, and another with higher HER2 expression 3. The study aims to evaluate how well these treatments control the cancer and their safety profiles. Participants in Cohort 1 will be randomly assigned to receive either BNT323 or a chemotherapy drug chosen by their doctor, such as doxorubicin or paclitaxel or docetaxel if paclitaxel is unsuitable. Cohort 2 participants will receive BNT323 alone. Treatments are given through intravenous infusions and continue until the cancer progresses, unacceptable side effects occur, or consent is withdrawn. The study includes screening, treatment lasting about six months, and long-term follow-up for up to 53 months to monitor survival and other outcomes. During the trial, participants will undergo various assessments including imaging scans to measure tumor size, evaluations of side effects, blood tests to study drug behavior and immune responses, and quality of life questionnaires. Safety follow-up occurs shortly after treatment ends, followed by extended monitoring for treatment effectiveness and survival. Participants are closely observed throughout to understand how well BNT323 works compared to chemotherapy and its impact on health and wellbeing.

Age: 18Years +FEMALEPhase 3
206 locations
S

Actively Recruiting

Researchers are investigating the frequency of Neuronal Ceroid Lipofusinosis Type 2 CLN2 in children aged 2 to 6 years who have nonspecific neurological symptoms such as idiopathic seizures, speech disorders, and motor dysfunctions. This multicenter, non-drug screening study focuses on children without hypoxic ischemic encephalopathy, head trauma, or developmental brain anomalies, aiming to better understand the demographic and clinical features of those with possible CLN2 disease. Children first undergo assessments including recording demographic and medical history, seizure frequency, cognitive and language development evaluations, physical exams assessing muscle strength, gait, and coordination, as well as neurological evaluations using EEG and MRI scans. Those showing specific signs like speech disorder with seizures, movement problems, particular EEG responses, or MRI findings will have blood samples taken to measure Tripeptidyl Peptidase 1 enzyme levels. If enzyme activity is low, genetic testing is performed to investigate CLN2 disease. Participants are involved for up to one year during which various clinical, neurological, and imaging evaluations are done. Blood samples are collected for enzyme and genetic analyses. The main outcome measured is the frequency of CLN2 disease in this group. The study tracks each childs symptoms, neurological findings, and imaging results to better identify and understand CLN2 in children with these symptoms.

Age: 2Years - 6YearsAll Genders
34 locations
E

Actively Recruiting

Researchers are evaluating the effects of disease management education on individuals diagnosed with hypertension, focusing on how such education impacts their perception of health and levels of burnout. This study addresses a gap in the literature by examining psychosocial outcomes of educational interventions, which are known to improve treatment success and long-term health by supporting active participation in disease management. The study is sponsored by Inonu University and aims to provide practical insights for both patient outcomes and healthcare practices. Participants are randomly assigned to one of two groups an experimental group receiving education three times, and a control group receiving standard medical treatment alone. The educational intervention is designed to enhance knowledge and self-management skills related to hypertension. Both groups are monitored over a period of three months. During the study, participants health perception is measured with a health perception scale, and burnout levels are assessed using a burnout scale at the three-month mark. Eligible participants must be literate, proficient in Turkish, and physically and cognitively able to complete data collection forms. The study involves outpatient and inpatient individuals from Batman Training and Research Hospital, with a total participation duration of three months.

Age: 18Years +All GendersPhase Not Applicable
1 location
E

Actively Recruiting

Researchers are evaluating the effect of mind mapping-based education on patients undergoing total knee arthroplasty, a surgery aimed at relieving pain and improving function in severe knee joint problems. The study compares this visual and structured education method with routine care to see if it helps reduce postoperative pain, fear of movement, and improves readiness for hospital discharge. Participants will be randomly assigned to one of two groups. One group will receive mind mapping-based education before and after surgery alongside routine care, providing organized visual information about the surgical process, pain management, mobilization, recovery, and discharge preparation. The other group will receive routine care and standard patient education without the additional mind mapping intervention. Throughout the study, participants will be assessed for changes in fear of movement, pain intensity, and readiness for discharge using specific measurement tools at baseline and during the first few days after surgery. The study aims to improve perioperative patient education and support recovery by measuring these outcomes around the time of surgery and discharge readiness.

Age: 18Years +All GendersPhase Not Applicable
1 location
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the use of a surgical incision drape to secure endotracheal tubes in preterm infants born between 28 and 34 weeks of gestation who are hospitalized in the neonatal intensive care unit. The study aims to reduce unplanned extubation events and skin damage caused by tube fixation, as well as to assess related complications. This randomized controlled trial compares the surgical drape method with the standard use of silk plasters. Participants will be randomly assigned to one of two groups one group will have their endotracheal tube secured using a surgical incision drape, and the other group will have the tube secured with silk plasters. The study collects data on skin moisture, skin pH, and neonatal skin condition using specialized devices and rating scales. Data will be gathered every 24 hours during the intubation period to compare the effects of the two fixation methods. During the study, researchers will record demographic data and monitor skin condition and moisture levels at the tube fixation site. These assessments will be done daily throughout the intubation period. The study aims to provide insights into skin wounds, unplanned extubation rates, skin pH, and moisture differences between the two groups. Data analysis will be performed using statistical software to evaluate these outcomes.

Age: 28Weeks - 34WeeksAll GendersPhase Not Applicable
1 location